This risk was initially reported in patients using paroxetine, but the FDA decided in 2004 to mandate the warning on suicidality for all antidepressants, including tricyclics.
The researchers used the Diagnostic Interview Schedule for Children to assess rates of posttraumatic stress disorder (PTSD), anorexia, bulimia, major depression, conduct disorder, and suicidality.
